Cargando…

VLPs containing stalk domain and ectodomain of matrix protein 2 of influenza induce protection in mice

BACKGROUND: As a result of antigenic drift, current influenza vaccines provide limited protection against circulating influenza viruses, and vaccines with broad cross protection are urgently needed. Hemagglutinin stalk domain and ectodomain of matrix protein 2 are highly conserved among influenza vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Lili, Long, Ying, Zhu, Yanyan, Dong, Jingjian, Chen, Yan, Feng, Hao, Sun, Xianliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972598/ https://www.ncbi.nlm.nih.gov/pubmed/36849974 http://dx.doi.org/10.1186/s12985-023-01994-4

Ejemplares similares

Virus-Like Particles Containing the Tetrameric Ectodomain of Influenza Matrix Protein 2 and Flagellin Induce Heterosubtypic Protection in Mice
por: Wang, Li, et al.
Publicado: (2013)

Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
por: Olukitibi, Titus Abiola, et al.
Publicado: (2022)

RNA: packaged and protected by VLPs
por: Fang, Po-Yu, et al.
Publicado: (2018)

Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions
por: Mittal, Nidhi, et al.
Publicado: (2021)

Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection
por: Wang, Bao-Zhong, et al.
Publicado: (2010)

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
por: Kang, Hae-Ji, et al.
Publicado: (2019)

The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines
por: Saelens, Xavier
Publicado: (2019)

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies
por: Oltean, Teodora, et al.
Publicado: (2022)

Vaccination with VLPs Presenting a Linear Neutralizing Domain of S. aureus Hla Elicits Protective Immunity
por: Joyner, Jason A., et al.
Publicado: (2020)

Cross-protective immunity of the haemagglutinin stalk domain presented on the surface of Lactococcus lactis against divergent influenza viruses in mice
por: Lei, Han, et al.
Publicado: (2020)

Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
por: Steel, John, et al.
Publicado: (2010)

Protective Immunity Based on the Conserved Hemagglutinin Stalk Domain and Its Prospects for Universal Influenza Vaccine Development
por: Khanna, Madhu, et al.
Publicado: (2014)

114 VLPs and particle vaccines
por: Buonaguro, Luigi
Publicado: (2014)

The influenza virus hemagglutinin head evolves faster than the stalk domain
por: Kirkpatrick, Ericka, et al.
Publicado: (2018)

A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody
por: De Baets, Sarah, et al.
Publicado: (2015)

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
por: Liu, Ye V., et al.
Publicado: (2011)

Packaging of actin into Ebola virus VLPs
por: Han, Ziying, et al.
Publicado: (2005)

An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice
por: Kim, Eun Hye, et al.
Publicado: (2017)

Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2
por: Feng, JingQi, et al.
Publicado: (2006)

Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
por: Li, Yulei, et al.
Publicado: (2023)

Introduction of Cysteines in the Stalk Domain of Recombinant Influenza Virus N1 Neuraminidase Enhances Protein Stability and Immunogenicity in Mice
por: Strohmeier, Shirin, et al.
Publicado: (2021)

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
por: Pushko, Peter, et al.
Publicado: (2020)

Natural and directed antigenic drift of the H1 influenza virus hemagglutinin stalk domain
por: Anderson, Christopher S., et al.
Publicado: (2017)

Functional RNAs: combined assembly and packaging in VLPs
por: Fang, Po-Yu, et al.
Publicado: (2017)

Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface
por: Wang, Dongliang, et al.
Publicado: (2018)

Investigation of the N-Glycosylation of the SARS-CoV-2 S Protein Contained in VLPs Produced in Nicotiana benthamiana
por: Balieu, Juliette, et al.
Publicado: (2022)

PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine
por: Dishlers, Andris, et al.
Publicado: (2023)

Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents
por: Umemoto, Shingo, et al.
Publicado: (2023)

Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design
por: C. Gomes, Ariane, et al.
Publicado: (2019)

Improving Influenza HA-Vlps Production in Insect High Five Cells via Adaptive Laboratory Evolution
por: Correia, Ricardo, et al.
Publicado: (2020)

SARS-CoV-2 RBD dimers elicit response comparable to VLPs in mice
por: Love, J., et al.
Publicado: (2023)

A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice
por: Bliss, Carly M., et al.
Publicado: (2022)

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations
por: Rajendran, Madhusudan, et al.
Publicado: (2018)

Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle
por: Kim, Ki-Hye, et al.
Publicado: (2022)

Mutations in the Hemagglutinin Stalk Domain Do Not Permit Escape from a Protective, Stalk-Based Vaccine-Induced Immune Response in the Mouse Model
por: Roubidoux, Ericka Kirkpatrick, et al.
Publicado: (2021)

Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands—A Role for CCL2
por: Gomes, Ariane C., et al.
Publicado: (2019)

Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
por: Zepeda-Cervantes, Jesús, et al.
Publicado: (2020)

2752. Peptide Vaccines Utilizing Conserved Hemagglutinin, Neuraminidase, and Matrix Ectodomain Influenza Epitopes Demonstrate Functional Activity Against Group 1 and 2 Influenza Strains
por: Sei, Clara J, et al.
Publicado: (2019)

Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses
por: Sun, Xianliang, et al.
Publicado: (2017)

HIV-1 sub-type C chimaeric VLPs boost cellular immune responses in mice
por: Pillay, Sirika, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ujakvfhbeeie91tqvp0a91nch4